Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Synaptic broadens access to drug design technology

Sep. 22, 2000

Study of pulmonary delivery of patented respiratory drug completed at Sheffield

Sep. 22, 2000

Sangamo establishes collaboration with Merck & Co.

Sep. 20, 2000

Deltagen and Glaxo Wellcome enter genetics agreements

Sep. 18, 2000

Cell growth switch enhances stem cell gene therapy

Sep. 18, 2000

Screening collaboration between CDD and CST to identify novel kinase inhibitors

Sep. 14, 2000

Synthetic antioxidant compounds extend the life span of C. elegans

Sep. 14, 2000

GlycoDesign and Seikagaku expand drug development agreement

Sep. 14, 2000

Medarex and Oxford GlycoSciences to codevelop human antibody therapeutics

Sep. 14, 2000

ImmunoGen and Abgenix form multiproduct collaboration

Sep. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...